240 related articles for article (PubMed ID: 8626851)
1. Daytime plasma melatonin levels in male hypogonadism.
Ozata M; Bulur M; Bingol N; Beyhan Z; Corakci A; Bolu E; Gundogan MA
J Clin Endocrinol Metab; 1996 May; 81(5):1877-81. PubMed ID: 8626851
[TBL] [Abstract][Full Text] [Related]
2. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
[TBL] [Abstract][Full Text] [Related]
3. Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency.
Luboshitzky R; Lavi S; Thuma I; Lavie P
J Clin Endocrinol Metab; 1996 Feb; 81(2):770-4. PubMed ID: 8636302
[TBL] [Abstract][Full Text] [Related]
4. Effects of gonadotropin and testosterone treatments on plasma leptin levels in male patients with idiopathic hypogonadotropic hypogonadism and Klinefelter's syndrome.
Ozata M; Ozisik G; Caglayan S; Yesilova Z; Bingöl N; Saglam M; Turan M; Beyhan Z
Horm Metab Res; 1998 May; 30(5):266-71. PubMed ID: 9660087
[TBL] [Abstract][Full Text] [Related]
5. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
6. Increased nocturnal melatonin secretion in male patients with hypogonadotropic hypogonadism and delayed puberty.
Luboshitzky R; Lavi S; Thuma I; Lavie P
J Clin Endocrinol Metab; 1995 Jul; 80(7):2144-8. PubMed ID: 7608268
[TBL] [Abstract][Full Text] [Related]
7. Abnormal melatonin secretion in male patients with hypogonadism.
Luboshitzky R; Wagner O; Lavi S; Herer P; Lavie P
J Mol Neurosci; 1996; 7(2):91-8. PubMed ID: 8873893
[TBL] [Abstract][Full Text] [Related]
8. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
Ley SB; Leonard JM
J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
[TBL] [Abstract][Full Text] [Related]
9. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
[TBL] [Abstract][Full Text] [Related]
10. Diurnal leptin secretion is intact in male hypogonadotropic hypogonadism and is not influenced by exogenous gonadotropins.
Kilciler G; Ozata M; Oktenli C; Sanisoglu SY; Bolu E; Bingol N; Kilciler M; Ozdemir IC; Kutlu M
J Clin Endocrinol Metab; 2002 Nov; 87(11):5023-9. PubMed ID: 12414867
[TBL] [Abstract][Full Text] [Related]
11. Nocturnal secretory patterns of melatonin, luteinizing hormone, prolactin and cortisol in male patients with gonadotropin-releasing hormone deficiency.
Luboshitzky R; Lavi S; Thuma I; Herer P; Lavie P
J Pineal Res; 1996 Aug; 21(1):49-54. PubMed ID: 8836964
[TBL] [Abstract][Full Text] [Related]
12. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
Wang C; Tso SC; Todd D
J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.
Sheckter CB; McLachlan RI; Tenover JS; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1221-4. PubMed ID: 3142917
[TBL] [Abstract][Full Text] [Related]
14. Antimüllerian hormone in patients with hypogonadotropic hypogonadism.
Young J; Rey R; Couzinet B; Chanson P; Josso N; Schaison G
J Clin Endocrinol Metab; 1999 Aug; 84(8):2696-9. PubMed ID: 10443662
[TBL] [Abstract][Full Text] [Related]
15. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
[TBL] [Abstract][Full Text] [Related]
16. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
Ozata M; Bulur M; Beyhan Z; Sengül A; Saglam M; Turan M; Corakci A; Ali Gundogan M
Endocr J; 1997 Oct; 44(5):719-24. PubMed ID: 9466329
[TBL] [Abstract][Full Text] [Related]
17. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
Smith R; Donald RA; Espiner EA; Stronach SG; Edwards IA
J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
[TBL] [Abstract][Full Text] [Related]
18. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
19. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
Büchter D; Behre HM; Kliesch S; Nieschlag E
Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
[TBL] [Abstract][Full Text] [Related]
20. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
